The Diabetes Hands Foundation (DHF) received a $200,000 grant from Novo Nordisk to hold programs that aim to bring people living with diabetes closer. This is one step in order to make sure that no one with the disease ever feels like being alone.
The President and Founder of the DHF, Manny Hernandez, commented in a press release: “We are truly grateful for Novo Nordisk’s deep commitment of resources and the positive impact this grant will have on every one of our programs in 2015. The generosity of this grant reflects Novo’s commitment to change diabetes by supporting efforts aimed at improving the daily lives of people touched by diabetes.”
DHF runs 2 online communities for people who are affected with diabetes: TuDiabetes (English) and EsTuDiabetes (Spanish). The communities have 66,000 members and almost 3 million visitors per year; those visits come from all over the world. A part of this grant is going to support the migration of these 2 online communities to adapt to a brand new software that will make them better prepared for the future.
The Big Blue Test is a another program run by DHF. Its goal is to demonstrate the positive impact exercise can have on blood sugar control, no matter how little the exercise may be. As it has been announced in the press release: “Each exercise session logged triggers matching grants to organizations serving people with diabetes living in need. Over the past five years over 100,000 exercise sessions have generated nearly $300,000 in grants. With this grant, Novo Nordisk becomes the first partner to get behind the Big Blue Test in 2015.”
The third program, Diabetes Advocates, also run by DHF, aims to link advocates dedicated to improve the lives of those that live with diabetes and accelerate their efforts combating the disease. This grant will allow to build a diabetes advocacy hub and all this is available online.
“We are delighted to partner with the Diabetes Hands Foundation on these critical programs that serve those affected by diabetes.Through DHF’s social networks and advocacy efforts they are reaching, and more importantly, connecting people with programs and services to support their diabetes journey,” said Diana Blankman, Novo Nordisk’s Senior Director.
